License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Acute graft-versus-host disease (aGvHD) is a major complication after hematopoietic stem cell transplantation (HSCT) and severity of aGvHD is associated with biological and genetic factors related to donors and recipients. Studies on inflammatory pathways involved in aGvHD have shown a significant impact of the gut microflora on aGvHD development giving increasing evidence in the understanding of the response of innate and adaptive immunity to microbial products. Cytokine deregulation may increase or reduce the risk of aGvHD. Damage of tissues affected by aGvHD reflects the immunological cascade of events in t...
Graft-versus-host disease, both acute and chronic (aGvHD, cGvHD) remains a major complication in pat...
The pathogenesis of acute graft versus host disease (GVHD) is multistep process. This review conside...
Allogeneic stem cell transplant (allo-SCT) is a curative therapy for malignant and non-malignant dis...
Copyright © 2015 Yuanyuan Chen et al.This is an open access article distributed under the Creative C...
Copyright © 2010 E. Holler et al. This is an open access article distributed under the Creative Comm...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an evidence based- cellular immuno...
<p>Animal models have indicated that intestinal microbiota influence acute graft-versus-host disease...
The use of allogeneic hematopoietic cell transplantation (HCT) has increased as new techniques have ...
Over the past five years, many novel approaches to early diagnosis, prevention, and treatment of acu...
Graft-versus-host disease (GVHD) is still one of the major causes of morbidity and mortality in allo...
Acute graft-versus-host disease (GVHD) is the most frequent, morbid complication following allogenei...
The human gut microbiota gained tremendous importance in the last decade as next-generation technolo...
According to the self-nonself model of immunity, allogeneic T cells are considered as major cause of...
Acute graft-versus-host disease (GVHD) afflicts as much as 80 % of all patients who receive an unrel...
Copyright © 2015 Riccardo Masetti et al. This is an open access article distributed under the Creati...
Graft-versus-host disease, both acute and chronic (aGvHD, cGvHD) remains a major complication in pat...
The pathogenesis of acute graft versus host disease (GVHD) is multistep process. This review conside...
Allogeneic stem cell transplant (allo-SCT) is a curative therapy for malignant and non-malignant dis...
Copyright © 2015 Yuanyuan Chen et al.This is an open access article distributed under the Creative C...
Copyright © 2010 E. Holler et al. This is an open access article distributed under the Creative Comm...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an evidence based- cellular immuno...
<p>Animal models have indicated that intestinal microbiota influence acute graft-versus-host disease...
The use of allogeneic hematopoietic cell transplantation (HCT) has increased as new techniques have ...
Over the past five years, many novel approaches to early diagnosis, prevention, and treatment of acu...
Graft-versus-host disease (GVHD) is still one of the major causes of morbidity and mortality in allo...
Acute graft-versus-host disease (GVHD) is the most frequent, morbid complication following allogenei...
The human gut microbiota gained tremendous importance in the last decade as next-generation technolo...
According to the self-nonself model of immunity, allogeneic T cells are considered as major cause of...
Acute graft-versus-host disease (GVHD) afflicts as much as 80 % of all patients who receive an unrel...
Copyright © 2015 Riccardo Masetti et al. This is an open access article distributed under the Creati...
Graft-versus-host disease, both acute and chronic (aGvHD, cGvHD) remains a major complication in pat...
The pathogenesis of acute graft versus host disease (GVHD) is multistep process. This review conside...
Allogeneic stem cell transplant (allo-SCT) is a curative therapy for malignant and non-malignant dis...